Cost Transformation

Case Study, by

Global Biotechnology Company

A rising cost base called for a multi-year, enterprise-wide transformation plan to deliver $300M in EBITDA improvement.

 

Dune Advisors led the Transformation Office, driving the enterprise savings agenda end-to-end: shaping the case-for-change, building consensus across the executive steering committee, and running senior leadership forums to sustain alignment and momentum.

 

$270M

EBITDA improvement achieved to date since launch